The warning letter follows inspections by the FDA at Dexcom’s manufacturing facilities in San Diego and Mesa, Ariz., and ...

DXCM faces an FDA warning over manufacturing issues, but operations remain unaffected. However, supply-chain risks and rising ...

The key differences between Dexcom and FreeStyle Libre include sensor characteristics, frequency of readings, minimum age of ...

Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...

The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...

We recently published a list of 10 Best Growth Stocks Under $100 to Buy Now. In this article, we are going to take a look at ...

DexCom said that on Tuesday it received a warning letter from the U.S. FDA following inspections at its facilities in San Diego, Calif., and Mesa, Ariz. related to concerns about manufacturing ...

In a regulatory filing, DexCom (DXCM) disclosed that on March 4, the company received a warning letter from the U.S. FDA following inspections ...

With the salesforce ramping up and regulatory approval of the 15-day G7 sensor expected this year, we anticipate Dexcom can return to double-digit top and bottom-line growth in 2025. We think the ...

DexCom, Inc. DXCM reported fourth-quarter 2024 adjusted earnings per share (EPS) of 45 cents, which missed the Zacks Consensus Estimate of 50 cents by 10%. The company reported earnings of 50 ...